Novocure
NVCR
#4028
Rank
$1.84 B
Marketcap
Jersey
Country
$17.35
Share price
-1.36%
Change (1 day)
-76.14%
Change (1 year)
Categories
Revenue for Novocure (NVCR)
Revenue in 2023 (TTM): $0.50 B
According to Novocure 's latest financial reports the company's current revenue (TTM) is $0.50 B. In 2022 the company made a revenue of $0.53 B an increase over the years 2021 revenue that were of $0.53 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novocure from 2015 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.50 B | -5.61% |
| 2022 | $0.53 B | 0.53% |
| 2021 | $0.53 B | 8.23% |
| 2020 | $0.49 B | 40.72% |
| 2019 | $0.35 B | 41.62% |
| 2018 | $0.24 B | 40.13% |
| 2017 | $0.17 B | 113.57% |
| 2016 | $82.88 M | 150.52% |
| 2015 | $33.08 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $0.44 M | -99.91% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $5.64 M | -98.89% | 🇬🇧 UK |
 Novavax NVAX | $1.44 B | 183.73% | 🇺🇸 USA |
 Novocure
NVCR | $0.50 B | 0.00% | Jersey |